MALTAGEN FORSCHUNG GMBH has a total of 12 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Germany, EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology and pharmaceuticals are YANSSEN BAJOTEK INK, AMSTERDAM MOLECULAR THERAPEUTICS BV and PERKINS EDWARD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Germany | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Stahl Rainer | 12 |
#2 | Dargatz Harald | 9 |
#3 | Luehrs Renate | 7 |
#4 | Berkemeyer Matthias | 5 |
#5 | Nelsen-Salz Birgit | 2 |
#6 | Wolf Norbert | 2 |
#7 | Luhrs Renate | 2 |
#8 | Wolf Norbert Dr | 1 |
#9 | Nelsen-Salz Birgit Dr | 1 |
Publication | Filing date | Title |
---|---|---|
DE102005035888A1 | New transgenic cereal plants that express the sweetener thaumatin, also related nucleic acid, protein, vectors and malted or milled products for use in foods | |
DE10343326A1 | New endosperm-specific plant promoter for crops | |
DE10145969A1 | Method for producing a marker vaccine against a mammalian virus |